Iovance Biotherapeutics (NASDAQ:IOVA) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday morning. Other analysts have also issued reports about the company. Chardan Capital dropped their target price on Iovance Biotherapeutics from $17.00 to $16.00 and set a [...]